2010
DOI: 10.1016/j.bcp.2010.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
47
0
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(54 citation statements)
references
References 40 publications
5
47
0
2
Order By: Relevance
“…In the present study, quercetin inhibited hypoxia-induced VEGF, which was in accord with the study of Anso et al (25). When cells were exposed to hypoxia in the presence of this flavonoid, HIF-1a translocated to the nucleus and interacted with p300/CBP, but this complex was transcriptionally inactive.…”
Section: Discussionsupporting
confidence: 93%
“…In the present study, quercetin inhibited hypoxia-induced VEGF, which was in accord with the study of Anso et al (25). When cells were exposed to hypoxia in the presence of this flavonoid, HIF-1a translocated to the nucleus and interacted with p300/CBP, but this complex was transcriptionally inactive.…”
Section: Discussionsupporting
confidence: 93%
“…However, the other flavonoid (DTFG) produced no suppression of the growth of the cancer cell, which suggested chemical group may impact the activation of flavonoid compound. The results of accumulated researches showed that the presence of an additional hydroxyl group at 4 0 of the B ring or 5 of A ring was important for antitumor activity of flavonoids (Anso et al, 2010;Lopez-posadas et al, 2008), which was also found in our research work. Accordingly, it was suggested that potential antitumor effects can be similarly revealed in other cancer cell lines.…”
Section: Discussionsupporting
confidence: 85%
“…19,20 Luteolin inhibits hypoxia-induced VEGF expression by a HIF-1 independent mechanism, suppression of STAT3 tyrosine phosphorylation. 21 In the present study, we demonstrated that luteolin effectively inhibited in vitro angiogenesis in HRMECs and retinal neovascularization in OIR without toxicity, which would be related to that luteolin effectively inhibited VEGF expression via HIF-1a dependent mechanism by blockade of ROS production, and VEGF-induced angiogenesis via regulating possibly VEGFR2 signaling pathway. Taken together, our results suggest that this anti-angiogenic activity of luteolin as an antioxidant could be applied to variable vasoproliferative retinopathies induced by ischemia as well as ROP.…”
Section: Discussionmentioning
confidence: 77%